Medtide Inc. (HKG:3880)
Hong Kong · Delayed Price · Currency is HKD 22.60
+0.32 (1.44%)
At close: Mar 6, 2026
Medtide Market Cap
Medtide has a market cap or net worth of 3.2 billion as of March 6, 2026.
Market Cap
3.20B
Enterprise Value
2.01B
Revenue
546.29M
Ranking
n/a
PE Ratio
23.31
Stock Price
22.60
Market Cap Chart
Since June 30, 2025, Medtide's market cap has decreased from 4.37B to 3.20B, a decrease of -26.62%. That is a compound annual growth rate of -36.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.20B | -25.85% |
| Dec 31, 2025 | 4.32B | -1.04% |
| Jun 30, 2025 | 4.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shandong Boan Biotechnology | 4.39B |
| Jacobio Pharmaceuticals Group | 4.31B |
| Viva Biotech Holdings | 4.20B |
| Mirxes Holding Company | 4.13B |
| TYK Medicines | 3.94B |
| Qyuns Therapeutics | 3.61B |
| AIM Vaccine | 3.61B |
| BioDlink International Company | 3.13B |